Inspira Technologies Oxy B.H.N. Ltd. (IINN): Price and Financial Metrics
IINN Price/Volume Stats
| Current price | $1.30 | 52-week high | $2.49 |
| Prev. close | $1.21 | 52-week low | $0.76 |
| Day low | $1.17 | Volume | 119,200 |
| Day high | $1.30 | Avg. volume | 517,003 |
| 50-day MA | $1.12 | Dividend yield | N/A |
| 200-day MA | $1.43 | Market Cap | 16.41M |
IINN Stock Price Chart Interactive Chart >
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Company Bio
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Latest IINN News From Around the Web
Below are the latest news stories about INSPIRA TECHNOLOGIES OXY BHN LTD that investors may wish to consider to help them evaluate IINN as an investment opportunity.
Inspira™ Technologies Closes on $3.88 Million Registered Direct OfferingInspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announces the closing of its previously announced registered direct offering of 3,031,250 ordinary shares (or ordinary share equivalents in lieu thereof), at a purchase price of $1.28 per ordinary share (or ordinary share equivalents in lieu thereof). Inspira has also issued in a private placement |
Inspira Announces $3.88 Million Registered Direct OfferingInspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,031,250 of ordinary shares (or pre-funded warrants in lieu thereof) at a purchase price of $1.28 per share (or per pre-funded warrants in lieu thereof) in a registered direct offering. The Co |
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024Inspira Technologies OXY BHN Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced a significant advancement in its sensor technology by its team of experts. This breakthrough, in achieving 95% accuracy compared to standard blood gas analyzers, brings continuous and real-time blood monitoring capabilities compared to traditional blood gas analyzer systems used in hospit |
Inspira Technologies to Participate in J.P. Morgan Healthcare ConferenceInspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced that its CEO and the Company's President will attend the upcoming 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-11, 2024 in San Francisco, California. |
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory BoardInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, is pleased to announce the appointment of Dr. Dan Gorfil to its medical advisory board. |
IINN Price Returns
| 1-mo | 20.54% |
| 3-mo | N/A |
| 6-mo | -27.78% |
| 1-year | -13.33% |
| 3-year | -57.10% |
| 5-year | N/A |
| YTD | 22.64% |
| 2023 | -17.83% |
| 2022 | -68.99% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...